DUX4 and sarcoma: To evaluate the SplitFusion algorithm in detecting highly repetitive genes, we used two clinical sarcoma cases (Massachesetts General Hospital [MGH] case #1 and case #2) with confirmed CIC::DUX4 fusion, detected using a clinically validated assay based on AMP targeted RNA-seq.